Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Submitted by
admin
on August 12, 2013 - 5:26pm
Source:
Bloomberg
News Tags:
GSK
FDA
HIV
ViiV Healthcare
Tivicay
Dolutegravir
Headline:
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Do Not Allow Advertisers to Use My Personal information
